What over-the-counter (OTC) medications, such as loperamide (Imodium) or bismuth subsalicylate (Pepto-Bismol), can be used to treat acute diarrhea in a patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Over-the-Counter Medications for Diarrhea

Loperamide (Imodium) is the preferred first-line over-the-counter medication for acute diarrhea in adults, with stronger evidence and faster symptom relief than bismuth subsalicylate (Pepto-Bismol). 1, 2, 3

Primary OTC Options

Loperamide (Imodium)

  • Dosing regimen: Start with 4 mg initially, then 2 mg after each loose stool, with a maximum of 16 mg per day 1, 4
  • Loperamide is FDA-approved for acute nonspecific diarrhea and provides faster, more complete relief than bismuth subsalicylate 5, 3
  • The medication takes 1-2 hours to reach therapeutic effect, so space additional doses accordingly to avoid rebound constipation 1, 4
  • Loperamide works by slowing intestinal motility and increasing fluid absorption, with minimal central nervous system effects due to poor blood-brain barrier penetration 6

Bismuth Subsalicylate (Pepto-Bismol)

  • Bismuth subsalicylate is less effective than loperamide but remains a reasonable alternative for mild diarrhea 1, 2, 3
  • Head-to-head trials show loperamide provides significantly faster time to last unformed stool and better overall subjective relief at 24 hours compared to bismuth subsalicylate 3, 7

Critical Safety Screening Before Use

Absolute Contraindications for Loperamide

  • Fever >38.5°C (101.3°F) - suggests invasive bacterial infection 4
  • Frank blood in stool - indicates possible inflammatory or invasive diarrhea 4
  • Severe abdominal pain or distention - risk of toxic megacolon 4
  • Suspected C. difficile infection (pseudomembranous colitis) - absolute contraindication 4
  • Children under 18 years of age - strongly contraindicated due to risks of respiratory depression and cardiac adverse reactions 4

When to Avoid Antimotility Agents

  • Slowing intestinal motility with invasive pathogens can lead to bacterial proliferation, toxin accumulation, and toxic megacolon 4
  • If any warning signs develop during treatment (fever, bloody stools, worsening abdominal pain), discontinue loperamide immediately and consider antibiotics 1, 4

Treatment Algorithm

Step 1: Ensure Adequate Hydration First

  • Rehydration is the first priority before considering any antimotility agent 4
  • Oral rehydration solution (ORS) is first-line therapy for mild to moderate dehydration 4

Step 2: Screen for Contraindications

  • Check for fever, blood in stool, severe abdominal pain, or suspected inflammatory conditions 4
  • Verify patient age (must be ≥18 years for loperamide) 4
  • Rule out C. difficile if patient has recent antibiotic exposure 4

Step 3: Initiate Loperamide for Uncomplicated Diarrhea

  • For mild-moderate watery diarrhea without warning signs: Loperamide 4 mg initially, then 2 mg after each loose stool (maximum 16 mg/day) 1, 4
  • Loperamide can be used as monotherapy for moderate travelers' diarrhea 1, 4

Step 4: When to Escalate to Antibiotics

  • For severe diarrhea or moderate diarrhea with fever/bloody stools: Combine loperamide with antibiotics (azithromycin preferred) 1, 4
  • Discontinue loperamide and start antibiotics if symptoms worsen or invasive features develop 1, 4

Special Populations and Contexts

Travelers' Diarrhea

  • Loperamide has strong guideline support and FDA-labeled indication for travelers' diarrhea 1, 4
  • Can be used alone for mild-moderate cases or combined with azithromycin for severe cases 1, 4

Chemotherapy-Related Diarrhea

  • Loperamide is recommended for uncomplicated grade 1-2 chemotherapy-induced diarrhea using the same dosing regimen 1, 4
  • For complicated cases (grade 3-4, fever, dehydration), hospitalization with IV fluids and octreotide is required 1

Chronic Diarrhea (IBS-D)

  • Loperamide 4-12 mg daily improves stool consistency and frequency in IBS-D but does not reliably improve urgency or global IBS symptoms 4
  • If inadequate response after 3-5 weeks, consider tricyclic antidepressants (amitriptyline 10-50 mg) as second-line treatment 4

Common Pitfalls to Avoid

  • Never use loperamide before ensuring adequate hydration - dehydration must be addressed first 4
  • Do not exceed 16 mg per day - higher doses increase risk of cardiac complications and severe constipation 1, 4
  • Avoid spacing doses too closely - allow 2-4 hours between doses to prevent rebound constipation 1, 4
  • Do not continue beyond symptom resolution - prolonged use increases constipation risk 4
  • Monitor for abdominal distention - discontinue immediately if this develops, as it suggests toxic megacolon 4

Efficacy Evidence

  • Loperamide reduces diarrhea prevalence at both 24 and 48 hours after treatment initiation with moderate-strength evidence 4
  • In healthy adults, loperamide has not been associated with increased adverse events beyond constipation 4
  • Loperamide is more effective than diphenoxylate and bismuth subsalicylate based on comparative trials 2, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Safety and efficacy of loperamide.

The American journal of medicine, 1990

Guideline

Appropriate Use of Anti-Motility Agents in Diarrhea

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Loperamide: a pharmacological review.

Reviews in gastroenterological disorders, 2007

Research

Nonantibiotic therapy for travelers' diarrhea.

Reviews of infectious diseases, 1986

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.